Japan: Historic switch for emergency contraception

October 2025. Today, ASKA Pharmaceutical, the marketing authorization holder of Japan’s only emergency contraceptive pill (ECP), announced it has received official approval to make the product available over the counter (OTC). This means people in Japan will soon be able to obtain emergency contraception directly from pharmacies without a prescription.

This marks a historic milestone for reproductive autonomy in Japan, aligning national policy with WHO recommendations that promote easier and safer access to emergency contraception.

Read ASKA’s official press release here.

Similar Posts

  • ECEC supports UPA OTC access

    Upon request by the manufacturer of ulipristal acetate emergency contraception (UPA EC) pills, the Committee for Medicinal Products for Human Use of the European Medicines Agency will consider a proposed change in the classification for supply of UPA EC pills from “medicinal product subject to medical prescription” to “medicinal product not subject to medical prescription”…

  • Spain: EC to be finally free in all public health services

    February 2023. In 2009, emergency contraception pills (ECPs) were reclassified to pharmacy products in Spain and prescription requirements were removed. This was a first measure to equalize access in all country’s territory.  Last week, a new step was taken in this direction: according to the text of the Reform of the law on Sexual and…

  • British Columbia: Free EC pills provided to 37.000 people since April

    December 2023. The Government of British Columbia (Canada) reported the results of the free contraceptive provision program, whichincludes LNG emergency contraceptive pills. Since April 2023, “more than 188.000 people received free contraceptives. This includes more than 123.000 people who received hormonal birth control pills, more than 30.000 people who received IUDs, and more than 37.000…

  • US FDA announcement on LNG EC efficacy and weight

    On May 24, 2016, the United States Food and Drug Administration (FDA) announced completion of a review of the existing data related to the efficacy of EC and body weight, concluding that the data do not warrant a change to product labels: “The FDA has completed a review of available scientific data concerning the effectiveness of levonorgestrel (LNG)…

  • Argentina: New data on EC use and access

    November 2024. The Study Lucía: Uses and preferences of contraceptive methods in women aged 15 to 49 years in Argentina, was recently published. This quantitative and qualitative research has consulted 2,000 women and people identifyin as LGTB from all over the nation. The study findings, published in September 2024, include valuable information about access to…

  • UPA and LNG EC pills in WHO’s List of Essential Medicines

    October 2025 — Last September, the World Health Organization (WHO) published the 24th Model List of Essential Medicines (EML). Levonorgestrel (LNG) emergency contraceptive pills (ECPs) have been included in the EML since 1999, and ulipristal acetate (UPA) ECPs since 2017, underscoring their continued importance in ensuring access to safe and effective reproductive health options. Essential…